Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Terumo ( (JP:4543) ) has issued an update.
Terumo Corporation announced an amendment to its Shareholder Benefit Program, effective from March 31, 2026. The changes aim to increase shareholder engagement by offering electronic coupons and exclusive benefits to long-term shareholders, thereby enhancing the investment appeal and promoting a deeper understanding of its business activities.
The most recent analyst rating on (JP:4543) stock is a Buy with a Yen2915.00 price target. To see the full list of analyst forecasts on Terumo stock, see the JP:4543 Stock Forecast page.
More about Terumo
Terumo Corporation operates in the healthcare industry, primarily focusing on medical devices and services. It is known for its innovative solutions in the medical field, aiming to enhance patient care and healthcare efficiency.
Average Trading Volume: 3,807,157
Technical Sentiment Signal: Buy
Current Market Cap: Yen3826.8B
For an in-depth examination of 4543 stock, go to TipRanks’ Overview page.